Publication | Open Access
Five-year results of patients supported by HeartMate II: outcomes and adverse events
26
Citations
25
References
2017
Year
This is the first single-cohort study to describe a 5-year survival of HMII patients on extended duration of support. A 5-year survival of 54% was observed in this single-centre cohort.
| Year | Citations | |
|---|---|---|
Page 1
Page 1